NNL Logo making fMRI easy



Partners

  Partners

Project Partners

IMAGEN
IMAGEN is a European Research Project which aims to identify and learn more about biological and environmental factors that might have an influence on mental health in teenagers. This knowledge will then help develop better prevention strategies and therapies in the future.

 

The IMAGEN Study
IMAGEN is (the first study on this research topic) a major European-Commission funded project, using state-of-the-art technology from the (field of) behavioural neuroscience field, a field where medicine, psychology, physics and biology intersect in the study of human behaviour.  

  • 2000 14 year old children with their parents/guardians as well as research teams from England, France, Ireland and Germany are involved in this project
  • We are conducting this study in order to better understand the teenage behaviour and mental health
  • The researchers want to find out what impact might certain attitudes and thinking styles, as well as certain brain activity patterns and genetic characteristics, have on teenage risk taking behaviour and mental health.
  • Research methods will include self-report questionnaires, behavioural assessment, interviews, neuroimaging of the brain as well as blood sampling for genetic analyses

IMAGEN is an Integrated Project funded by the European Commission in the 6th Framework Program "Life Science" (LSHM-CT-2007-037286 - IMAGEN - Reinforcement-related behaviour in normal brain function and psychopathology). It consists of 17 parties across Europe and is coordinated by the Institute of Psychiatry King's College London, United Kingdom.

 

Click here for more information.


Medical Imaging Laboratory (MI Lab)

In 2006, the Norwegian Research Council appointed 14 "Centres for Research-based Innovation" (CRIs) to boost innovation in Norwegian industry by strengthening long-term collaborations between research-intensive enterprises and prominent research groups at universities. Medical Imaging Laboratory (MI Lab) at the NTNU Trondheim is one of three participating research groups in the area of medicine, and together with a number of excellent collaborators, NordicNeuroLab and NordicImagingLab have become industrial partners of MI Lab. The overall goal of MI Lab is to facilitate cost effective health care and improved patient treatment through innovation in the field of medical imaging.
MI Lab is aiming to:  

  • Provide advanced MR and ultrasound protocols to small local hospitals and imaging centers for early diagnosis of life-threatening and debilitating diseases and more frequent and cost-effective follow-up of patients with chronic diseases.
  • Enable more universal and safer implementation of minimally invasive surgery: combining intra-operative imaging, surgical navigation, pre-operative imaging information displayed in the operating theater, and post-operative imaging for early detection of complications.
  • Provide improved image-based biological information to support medical decision-making through the use of acquisition protocols that integrate anatomical, functional, metabolic and molecular imaging, and information from genomics and biotechnological investigations of representative biopsies.
  • Increase the international success of Norwegian industrial enterprise: conquering new markets with innovative next-generation medical imaging products and applications.

Our main motivation for joining MI Lab is the focus on MR imaging and the opportunity to extend our existing product portfolio by developing new clinical applications for brain-related disorders. The MI Lab will give the companies a unique possibility for new research-based innovation that may significantly improve the potential for success on the global market.

 

Click here for more information.

 

 

SINAPSE
SINAPSE is a consortium of six Scottish universities; Aberdeen, Dundee, Edinburgh, Glasgow, St. Andrews and Stirling. It has been established with funding from the Scottish Funding Council, the Chief Scientist's Office and the six Universities. The aim of this world-class consortium is to create a strong dynamic network for a shared environment for strategic research development in brain imaging.

 

The focus is primarily on the technologies of magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), and electrophysiology (EEG). The network has increased the number of key research staff and students within Scotland and it allows the sharing of skills and education via e-learning, seminars and other key events. The formation of SINAPSE has increased the imaging capability of participating sites as it has facilitated cutting edge imaging equipment for the Scottish brain research community, which is compatible between imaging centres thus enhancing multi-centre trials and research.

 

fMRI research in Scotland now goes from cognitive neuroscience to clinical evaluation. Current research covers areas of basic cognitive processes such as human voice perception, visual illusions and perception, memory, and normal aging, to applications to various diseases such as developmental disorders in infancy, cognitive impairments in psychiatric disorders or surgical planning for patients with brain tumours. All scanners operate to a common quality assurance programme thus facilitating multicentre imaging studies. Work is now going on with people from all over the world and we welcome new collaborations.

 

Click here for more information.


Quantitative Imaging Biomarkers Alliance (QIBA)
QIBA is an initiative designed to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice by engaging researchers, healthcare professionals and industry. This involves collaborating to identify needs, barriers, and solutions to develop and test consistent, reliable, valid, and achievable quantitative imaging results across imaging platforms, clinical sites, and time. As well as accelerating the development and adoption of hardware and software standards needed to achieve accurate and reproducible quantitative results from imaging methods.

 

The QIBA effort is supported by the Radiological Society of North Ameria (RSNA), which is committed to helping transform radiology from a qualitative to a more quantitative science. The QIBA initiative is composed of a Steering Committee with 3 modality committees (CT, PET and MR) and 5 technical working groups (Volumetric CT, oncology; CT density, COPD; FDG-PET, oncology; DCE-MRI, oncology; and BOLD fMRI, oncology and seizure disorders.

 

The fMRI Subcommittee is co-chaired by Jeffrey Petrella, MD (Duke University) and Cathy Elsinger PhD (NNL) and composed of many scientists, clinicians and engineers from academia and medical centers and industry, devoted to the mission of assessing and improving the reproducibility, accuracy and precision of functional imaging biomarkers that result from BOLD imaging. An ultimate goal of this committee is to provide a profile which consists of a set of guidelines for implementing and optimizing fMRI protocols and associated outcome measures, defining what the quantitative outcome measures are for the specific use case (e.g. presurgical mapping).

 

Click here for more information.